Keywords: Lundbeck, Akron, Nembutal,Cogentin, Diuril, USA

Lundbeck divests three branded injectables to Akorn

Article | 23 December 2011

Print This

Danish CNS drug specialist Lundbeck (LUND: DC) says it has entered into an agreement with USA-based niche generic drugmaker Akorn ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in